Pfizer’s Omicron vaccine to begin human trials late January
January 11, 2022Manufacturing and Production
Albert Bourla, the CEO of Pfizer, said a COVID-19 vaccine specifically targeting the Omicron variant of the virus, alongside other …
Trial finds new CAR T-cell therapy is effective at killing cancer cells
January 10, 2022Sales and Marketing
A Phase I clinical trial funded by the NIHR Invention for Innovation (i4i) programme, and supported by the NIHR UCLH …
European Commission approves Lumykras for lung cancer patients
January 10, 2022Sales and Marketing
The European Commission (EC) has granted conditional marketing authorisation for Lyumykras (sotorasib), a first-in-class KRAS inhibitor, for the treatment of …
FDA approval of QUVIVIQ (daridorexant) for the treatment of insomnia
January 10, 2022Sales and Marketing
Idorsia Ltd has announced the FDA approval of QUVIVIQ™ (daridorexant) 25 mg and 50 mg for the treatment of adult …
Phase III trial into lebrikizumab shows positive results for atopic dermatitis patients
January 10, 2022Sales and Marketing
Almirall has reported positive results from their Phase III trial into lebrikizumab, which demonstrated significant improvement and itch relief when …
Canada to procure 20,000 doses of GSK COVID-19 antibody therapy
January 7, 2022Medical Communications
GlaxoSmithKline Plc. has shared that it has signed agreements with the Government of Canada to supply 20,000 doses of Sotrovimab, …
Judge orders FDA to produce Pfizer safety data in eight months
January 7, 2022Medical Communications
A federal judge has ordered the FDA to make public tens of thousands of more pages on the data it …
J&J COVID-19 vaccine shows protection against breakthrough infection for up to six months
January 7, 2022Medical Communications
J&J have announced new results from the largest study to date on the durability of COVID-19 vaccines in the US. …
Neurimmune and AstraZeneca collaborate to develop human monoclonal antibody
January 7, 2022Medical Communications
Neurimmune AG announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca Rare Disease …
FDA grant Breakthrough Therapy Designation to telisotuzumab vedotin
January 6, 2022Business Services
AbbVie’s investigational telisotuzumab vedotin has been granted Breakthrough Therapy Designation by the FDA for the treatment of patients with advanced …
Cyclenium Pharma and Vuja De Sciences collaborate on oncology drug discovery
January 6, 2022Business Services
Cyclenium Pharma, an emerging pharmaceutical company, have announced a collaboration with Vuja De Sciences, to screen and optimise lead candidates …
FDA grants regenerative medicine advanced therapy designation to AlloVir’s posoleucel
January 6, 2022Business Services
The FDA has granted AlloVir’s posoleucel Regenerative Medicine Advanced Therapy Designation (RMAT), for the treatment of adenovirus infections in adults …
Jazz Pharmeuticals announces Phase III data of idiopathic hypersomnia treatment
January 6, 2022Business Services
Jazz Pharmaceuticals have announced that positive data, from the Phase III of Xywav oral solution for the treatment of adults …
Bharat Biotech receives approval to test nasal COVID-19 shot as booster
January 5, 2022Research and Development
India’s drug regulator has granted approval to Bharat Biotech, for late stage trials of its nasal COVID-19 vaccine to be …
FDA grants breakthrough therapy designation to novel EGFR inhibitor
January 5, 2022Research and Development
The FDA has granted a breakthrough therapy designation to Cullian Oncology’s CLN-081, in certain patients with locally advanced or metastatic …
NaNotics and Mayo Clinic to collaborate on nanomedicine cancer treatment
January 5, 2022Research and Development
Nanomedical company NaNotics have announced a research collaboration with Mayo Clinic, to develop a NaNot that targets the soluble form …
NICE recommends PONVORY for the treatment of relapsing forms of multiple sclerosis
January 5, 2022Research and Development
NICE has issued a positive Final Appraisal Document (FAD) recommending PONVORY® (ponesimod) as an option in England and Wales for …
Further evidence shows Omicron causes milder symptoms
January 4, 2022A WHO official has said more evidence is emerging to support that the Omicron variant causes milder symptoms than previous …
Theranos founder Elizabeth Holmes found guilty of fraud
January 4, 2022Manufacturing and Production
Elizabeth Holmes, founder of Theranos, has been found guilty on four of 11 charges of fraud, including one count of …
FDA expands Pfizer COVID-19 booster shot EUA for children aged 12-15
January 4, 2022Manufacturing and Production
The FDA has bypassed its advisory panel and extended its Emergency Use Authorisation (EUA) for Pfizer BioNTech’s COVID-19 booster vaccine …
Latest content
